Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Meningioma × Everolimus × Clear all

Phase

Status

Sponsor Class

OTHER 6 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Gliosarcoma 2 Glioblastoma 2 Central Nervous System Neoplasms 2 Breast Neoplasms, Male 2 Breast Neoplasms 2 Waldenstrom Macroglobulinemia 1 Somatostatinoma 1 Sarcoma 1 Rhabdoid Tumor 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Osteosarcoma 1 Meningioma 1 Medulloblastoma 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Mantle-Cell 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Kidney Neoplasms 1 Insulinoma 1 Immunoblastic Lymphadenopathy 1 Glucagonoma 1 Glioma 1

Interventions

Radiotherapy 2 Hydroxyurea 2 lutetium Lu 177 dotatate 1 emvododstat 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Proton Therapy 1 Octreotide 1 Observation 1 Mifepristone 1 Ifosfamide 1 Everolimus 1 Chemotherapy, Adjuvant 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡